Raymond James & Associates’s Invesco S&P SmallCap Health Care ETF PSCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$262K Buy
5,675
+68
+1% +$3.08K ﹤0.01% 3472
2024
Q2
$239K Sell
5,607
-305
-5% -$12.9K ﹤0.01% 3512
2024
Q1
$259K Sell
5,912
-419
-7% -$17.8K ﹤0.01% 3462
2023
Q4
$271K Sell
6,331
-3,034
-32% -$114K ﹤0.01% 3342
2023
Q3
$352K Sell
9,365
-10,312
-52% -$430K ﹤0.01% 3094
2023
Q2
$874K Buy
19,677
+114
+0.6% +$5.04K ﹤0.01% 2556
2023
Q1
$854K Sell
19,563
-390
-2% -$17.6K ﹤0.01% 2550
2022
Q4
$878K Buy
19,953
+336
+2% +$15.1K ﹤0.01% 2510
2022
Q3
$861K Buy
19,617
+1,509
+8% +$72.5K ﹤0.01% 2498
2022
Q2
$826K Sell
18,108
-1,866
-9% -$89K ﹤0.01% 2576
2022
Q1
$1.07M Sell
19,974
-13,758
-41% -$731K ﹤0.01% 2543
2021
Q4
$2.02M Sell
33,732
-1,428
-4% -$85.7K ﹤0.01% 2168
2021
Q3
$2.14M Buy
35,160
+11,664
+50% +$730K ﹤0.01% 2050
2021
Q2
$1.52M Buy
23,496
+2,928
+14% +$182K ﹤0.01% 2304
2021
Q1
$1.26M Sell
20,568
-5,853
-22% -$362K ﹤0.01% 2340
2020
Q4
$1.5M Sell
26,421
-36,198
-58% -$1.81M ﹤0.01% 2078
2020
Q3
$2.76M Sell
62,619
-4,122
-6% -$176K ﹤0.01% 1558
2020
Q2
$2.69M Sell
66,741
-34,314
-34% -$1.31M ﹤0.01% 1546
2020
Q1
$3.48M Sell
101,055
-6,066
-6% -$248K 0.01% 1250
2019
Q4
$4.61M Sell
107,121
-3,414
-3% -$138K 0.01% 1312
2019
Q3
$4.18M Sell
110,535
-7,152
-6% -$277K 0.01% 1328
2019
Q2
$4.63M Sell
117,687
-30,516
-21% -$1.15M 0.01% 1257
2019
Q1
$5.71M Sell
148,203
-4,002
-3% -$156K 0.01% 1118
2018
Q4
$5.46M Sell
152,205
-7,074
-4% -$290K 0.01% 1056
2018
Q3
$7.45M Buy
159,279
+18,048
+13% +$830K 0.01% 998
2018
Q2
$6.05M Buy
+141,231
New +$5.72M 0.01% 1078

Other funds holding PSCH

Raymond James & Associates's PSCH Position: Q3 2024 in Review

Raymond James & Associates increased its Invesco S&P SmallCap Health Care ETF (PSCH) stake by 1.2% in Q3 2024, buying an estimated $3.08K and bringing the position to 5,675 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #3472.

Raymond James & Associates first reported a position in PSCH in Q2 2018 and has held it in 26 quarters since. The position peaked at $7.45M in Q3 2018. 79 funds tracked by Wall St. Rank hold PSCH as of Q3 2024.

  • Raymond James & Associates held 5,675 shares of Invesco S&P SmallCap Health Care ETF worth $262K as of Q3 2024.
  • Raymond James & Associates bought 68 Invesco S&P SmallCap Health Care ETF shares in Q3 2024, an estimated $3.08K.
  • Invesco S&P SmallCap Health Care ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3472 holding.
  • Raymond James & Associates first reported a position in Invesco S&P SmallCap Health Care ETF in Q2 2018 and has held it in 26 quarters since.
  • Raymond James & Associates's Invesco S&P SmallCap Health Care ETF position peaked at $7.45M in Q3 2018.
  • 79 funds tracked by Wall St. Rank held Invesco S&P SmallCap Health Care ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.